Cefiderocol is a new siderophore-beta-lactam antibiotic used for the treatment of severe multidrug-resistant infections like sepsis, hospital-acquired and ventilator-associated pneumonia in adults, but there are only single reports on its use in the neonatal population. We describe the successful cefiderocol treatment of a newborn with pneumogenic sepsis due to Stenotrophomonas maltophilia.
- Trauth, J.
- Schuler, R.
- Waitz, M.
- Ehrhardt, H.
- Fritzenwanker, M.
- Herold, S.
Keywords
- Stenotrophomonas maltophilia
- Cefiderocol
- Multi drug resistance
- Neonate
- Pneumogenic sepsis
